Sign in

CIK 0001776985 · Large accelerated filer

BioNTech SE

Sign in to watch
Ticker
BNTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Germany
Entity type
other
Phone
0049613190840
Business address
AN DER GOLDGRUBE 12, MAINZ, Germany, 55131
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 4 Planned sale Chief Executive Officer sold 63,209 shares at an average $94.07 ($5,945,855)
  10. 4 Planned sale Chief Executive Officer sold 24,000 shares at $95.86 ($2,300,633)
  11. 4 Planned sale Chief Executive Officer sold 93,000 shares at an average $97.14 ($9,033,642)
  12. 4 Planned sale Chief Executive Officer sold 34,000 shares at an average $97.09 ($3,301,069)
  13. 4 Planned sale Chief Executive Officer sold 66,000 shares at an average $98.19 ($6,480,659)
  14. 4 Planned sale Chief Executive Officer sold 61,000 shares at an average $98.57 ($6,012,500)
  15. 4 Planned sale Chief Executive Officer sold 69,000 shares at an average $99.17 ($6,842,742)
  16. 4 Planned sale Chief Executive Officer sold 79,000 shares at an average $99.50 ($7,860,757)
  17. 4 Planned sale Chief Executive Officer sold 64,000 shares at an average $97.49 ($6,239,071)
  18. 6-K Event Report of Foreign Issuer
  19. 4 Planned sale Chief Executive Officer sold 49,000 shares at an average $96.37 ($4,721,976)
  20. 4 Planned sale Chief Executive Officer sold 86,000 shares at an average $98.13 ($8,439,336)

Page 1 of 30 · 590 filings